Trial Profile

Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline Biologicals' Pneumococcal Vaccine GSK1024850A Following Primary and Booster Vaccination of Healthy Japanese Children

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 29 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; DTaP vaccine
Indications Diphtheria; Pertussis; Pneumococcal infections; Pneumonia; Streptococcal infections; Tetanus
Focus Pharmacodynamics; Registrational
Sponsors GlaxoSmithKline; GSK

30 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
19 Aug 2011 Planned end date changed from 1 Oct 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
27 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com